Rasche et al. demonstrated that there is a variation in GRP78 expression on the cellular surface starting from monoclonal gammopathy of undetermined significance (MGUS) to advanced relapsed and refractory to BTZ and LEN MM. This evidence concerns the gene HSPA5 and Miyoshi myopathy.